Beneficient AI Stock Analysis
Want to see BENF full AI Analyst Report?
Beneficient (BENF) AI Stock Analysis
Beneficient
(NASDAQ:BENF)
BENF scores near the bottom of the range, driven primarily by extreme financial distress: years of negative revenue, a $2.1B FY2024 net loss, a 92% erosion of the asset base, chronically negative equity, and relentless cash burn of roughly $67M per year with no visible path to profitability. Technicals reinforce the risk, with the stock trading far below all major moving averages and negative MACD momentum. Valuation offers no support given negative earnings and no dividend. Potential catalysts exist — litigation that could erase ~$130M of contested debt, insider buying, and the AltLens platform launch — but these are speculative and offset by a Nasdaq continued-listing deficiency notice with a May 2027 compliance deadline. This remains a highly speculative, distressed situation.
Beneficient (BENF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $9.72M
- Dividend Yield
- ―
- Average Volume (3M)
- 9.77M
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- 2.10
- Revenue Growth
- -38.32%
- EPS Growth
- 94.03%
- Country
- US
- Employees
- 50
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management
Beneficient Business Overview & Revenue Model
Company Description
Beneficient operates as a technology-driven financial services provider, specializing in delivering liquidity solutions to entities within the alternative asset market. The company manages the AltAccess platform, a comprehensive digital ecosystem des...
Beneficient Earnings Call Summary
The call described several important stabilizing and corrective actions — regaining NASDAQ compliance, a GWG settlement within insurance limits, cost reductions (6.5% quarter, 18% YTD), $50M in proceeds and targeted debt paydowns — that position the company to rebuild momentum. However, these positives are counterbalanced by material operational and financial challenges: large quarterly and year-to-date operating losses, negative adjusted revenues, substantial declines in investments and NAV (roughly 29% and ~32%, respectively), reduced interest income (down ~25% YTD), low cash versus ~$100M of debt largely tied to former CEO-related entities, and ongoing legal uncertainty tied to the former CEO. Given the scale of the financial deterioration and lingering legal/balance-sheet risks relative to the accomplishments, the negatives outweigh the positives.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management’s forward guidance emphasized stabilizing and re‑scaling the core liquidity and GP primary‑financing business while continuing expense and capital‑structure simplification: they plan further expense reductions after already cutting adjusted operating expenses 6.5% year‑over‑year and 18% year‑to‑date (ex. one‑time items), intend to close additional liquidity and GP primary financings (having closed a ~$3.0M NAV deal in December) and to act on a spring pipeline of opportunities, and will leverage a technology/AI‑enhanced platform to increase loan‑portfolio capacity (current net loan portfolio $188M, investments at fair value ~$206M). Management also reiterated balance‑sheet priorities — having generated about $50M gross proceeds from asset sales/redemptions (used in part to reduce debt, including ~$27.5M to a Texas State Bank), ending the quarter with $7.9M cash and $100.3M total debt (all but $3.7M tied to the former CEO’s entities) — and said it will consider litigation to challenge over $100M (≈$120M) of purported debt; they noted a $44.1M fair‑value increase in a derivative that settles in January 2028 and signaled plans to broaden channels (advisers, family offices, private banks) and demonstrate the business via a handful of transactions.
Beneficient Financial Statement Overview
Summary
Financials are severely distressed across all three statements. The income statement (score 5/10 scale equivalent) shows multiple years of negative revenue, a $2.1B net loss in FY2024, and deeply negative EBIT/EBITDA. The balance sheet reflects years of negative stockholders' equity, a 92% collapse in total assets from $3.1B to $239M, and technical insolvency on a book-value basis. Cash flow is persistently negative, with TTM operating and free cash flow at -$67M and no period of positive cash generation. Marginal TTM improvements (positive revenue of $9.6M, positive equity of $91M) are too small to offset acute going-concern risk.
Income Statement
5Very NegativeBalance Sheet
8Very NegativeCash Flow
6Very Negative| Breakdown | TTM | Mar 2026 | Jun 2025 | Jun 2024 | Mar 2023 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.65M | -39.13M | -7.95M | -98.91M | -104.99M | 101.98M |
| Gross Profit | 17.89M | -859.00K | -24.80M | -164.04M | -150.52M | 81.20M |
| EBITDA | -51.66M | -144.97M | -35.40M | -2.64B | -234.09M | -13.81M |
| Net Income | -29.13M | -87.43M | 51.16M | -2.10B | -130.98M | -58.04M |
Balance Sheet | ||||||
| Total Assets | 250.94M | 238.77M | 354.88M | 368.50M | 368.50M | 3.14B |
| Cash, Cash Equivalents and Short-Term Investments | 7.63M | 2.54M | 1.35M | 7.91M | 7.91M | 70.59M |
| Total Debt | 96.78M | 96.78M | 117.90M | 130.25M | 130.25M | 171.59M |
| Total Liabilities | 344.50M | 337.53M | 299.27M | 309.57M | 309.57M | 241.43M |
| Stockholders Equity | -210.40M | -214.02M | -167.00M | -234.35M | -234.35M | 1.44B |
Cash Flow | ||||||
| Free Cash Flow | -66.72M | -38.81M | -38.80M | -59.98M | -97.19M | -57.23M |
| Operating Cash Flow | -66.72M | -38.72M | -37.70M | -58.22M | -95.12M | -54.01M |
| Investing Cash Flow | 100.91M | 61.21M | 28.11M | 44.06M | 63.02M | -5.98M |
| Financing Cash Flow | -29.70M | -21.29M | 2.97M | 12.59M | -34.46M | 43.86M |
Beneficient Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BENF, the sentiment is Negative. The current price of 0.63 is below the 20-day moving average (MA) of 0.77, below the 50-day MA of 1.03, and below the 200-day MA of 2.84, indicating a bearish trend. The MACD of -0.14 indicates Negative momentum. The RSI at 36.15 is Neutral, neither overbought nor oversold. The STOCH value of 9.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BENF.
Beneficient Risk Analysis
Beneficient disclosed 131 risk factors in its most recent earnings report. Beneficient reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksBeneficient Peers Comparison
Overall Rating
BCG67Neutral
MLCI53Neutral- BENF39Underperform
CWD37Underperform
BTTC34Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| BCG | 67Neutral | $21.15M | 5.48 | 30.04% | ― | 8.30% | 426.61% |
| MLCI | 53Neutral | $38.99M | -0.58 | -63.29% | 3.44% | 47.32% | -117.27% |
| BENF | 39Underperform | $11.94M | -0.01 | 14.09% | ― | -38.32% | 94.03% |
| CWD | 37Underperform | $3.99M | -0.08 | 3235.42% | ― | -31.34% | 86.63% |
| BTTC | 34Underperform | $4.75M | 0.00 | <0.01% | ― | ― | -8154.56% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BENF | Beneficient | 0.63 | -3.43 | -84.53% | |
| BTTC | Black Titan Corporation | 0.32 | -2.74 | -89.67% | |
| BCG | Binah Capital Group, Inc. | 1.24 | -0.23 | -15.65% | |
| CWD | CaliberCos, Inc. Class A | 0.38 | -1.78 | -82.27% | |
| MLCI | Mount Logan Capital Inc | 3.48 | -3.97 | -53.23% |
Beneficient Corporate Events
Beneficient Receives Nasdaq Continued Listing Compliance Notice
NegativeOn November 5, 2026, Beneficient was notified that its market value of listed securities had remained below Nasdaq’s $35 million continued-listing requirement for 30 consecutive business days from September 24 through November 4, 2026; it also did no...
Beneficient Stockholders Approve Nasdaq-Related Share Issuance Proposal
NeutralBeneficient held a special meeting on October 29, 2026, where holders representing about 74.0% of voting power participated. Stockholders approved a Nasdaq-related proposal authorizing the issuance of Class A shares to Yorkville under an amended stan...
Beneficient Challenges HCLP Debt, Seeks Balance Sheet Relief
PositiveOn October 28, 2026, Beneficient announced that on October 23, 2026, it and certain subsidiaries moved to intervene in Delaware Court of Chancery litigation brought by HCLP Nominees against Delaware Trust Company, seeking to invalidate HCLP credit ag...
Beneficient Extends Key Related-Party Debt Payment Deadline
PositiveOn March 10, 2026, Beneficient Financing, L.L.C., together with Beneficient Company Holdings, L.P., entered into a letter agreement with lender and administrative agent HH-BDH, LLC to settle remaining interest and fees under an October 19, 2023 Credi...
Beneficient Unveils Strategy to Eliminate Fraudulent Debt Claims
PositiveOn September 23, 2026, Beneficient announced a comprehensive strategy to eliminate what it describes as fraudulent indebtedness claimed by HCLP Nominees and to cancel the equity interests in the company and its subsidiaries held by former CEO Brad He...
Beneficient Unveils AltLens Alternative Asset Analytics Platform
PositiveOn September 18, 2026, Beneficient announced plans to roll out AltLens, an alternative asset portfolio analytics and risk platform targeted at family offices and small institutional investors, with launch expected in the fourth quarter of 2026. Posit...
Beneficient Executives Increase Holdings Via Private Share Purchases
PositiveOn September 15, 2026, Beneficient entered into subscription agreements with directors Peter T. Cangany Jr. and Derek L. Fletcher and Chief Executive Officer James G. Silk for purchases of Class A common stock at $1.06 per share. Cangany, Fletcher an...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 13, 2026